Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Inhibitory Effect of a Novel DNA Aptamer with Artificial Nucleic Bases for Von Willebrand Factor A1 Domain on Platelet Thrombosis Formation

Kazuya Sakai, MD, Hideo Yagi, MD, Masaki Hayakawa, MD, Tatsuhiko Someya, PhD, Kaori Harada, PhD, Masanori Matsumoto, MD

Blood (2018) 132 (Supplement 1): 2522.

https://doi.org/10.1182/blood-2018-99-113948

Published: 2018

Journal Articles

International, Practice-Based Recommendations for Prediction of Bleedings and Anti-Platelet/Anti-Coagulant (AP/AC) Co-Medications in CLL Patients Taking Ibrutinib

Evgeny Nikitin, MD, Jennifer Series, Aleksandr Poletaev, Mikhail Panteleev, PhD Dr.Sc, Prof., Georg Hopfinger, MD, Vadim Ptushkin, MD, Ulrich Jaeger, MD, Bernard Payrastre, PhD, Loic Ysebaert, MD PhD

Blood (2017) 130 (Supplement 1): 1711.

https://doi.org/10.1182/blood.V130.Suppl_1.1711.1711

Published: 2017

Journal Articles

Low Intensity Vibration Treatment Reduces Myeloma Cell-Induced Osteoclast Formation By Inhibiting IL-6 and GFI-1 Production By MM Cells

Gabriel M. Pagnotti, PhD, Noriyoshi Kurihara, DDS, PhD, G David Roodman, MD PhD

Blood (2017) 130 (Supplement 1): 1775.

https://doi.org/10.1182/blood.V130.Suppl_1.1775.1775

Published: 2017

Journal Articles

Differentially Expressed Protein Patterns in Chronic Lymphocytic Leukemia (CLL) after Thymosin beta4 (Tb4) and Lenalidomide (Len) Treatment: Two-Dimensional Gel Electrophoresis (2DE) Analysis

Sabrina Bossio, Laura De Stefano, Mariavaleria Pellicanò, PhD, Angela Palummo, Francesca Storino, Nadia Caruso, Giovanni Iaquinta, Giovanna Cutrona, PhD, Massimo Gentile, MD, Ernesto Vigna, Anna Grazia Recchia, PhD, Fortunato Morabito, MD, Antonino Neri, MD

Blood (2015) 126 (23): 1729.

https://doi.org/10.1182/blood.V126.23.1729.1729

Published: 2015

Journal Articles

Laboratory Assessment of Anti-Coagulant Properties of a Von Willebrand Factor Targeted Aptamer

Deborah A. Lewis, PhD, Shahid M. Nimjee, MD, PhD, George A. Pitoc, D.V.M., M.S., Shoeb Khan, PhD, Richard C. Becker, MD, Bruce A. Sullenger, PhD, Thomas L. Ortel, MD, PhD

Blood (2014) 124 (21): 4279.

https://doi.org/10.1182/blood.V124.21.4279.4279

Published: 2014

Journal Articles

Loss of PTEN in Pediatric T-Cell Acute Lymphoblastic Leukemia Patients: Proteomic and Molecular Characterization

Paola Bonaccorso, Cristina Bugarin, Chiara Buracchi, Grazia Fazio, Maddalena Paganin, Giuseppe Basso, Andrea Biondi, Giovanni Cazzaniga, Luca Lo Nigro, Giuseppe Gaipa

Blood (2014) 124 (21): 2408.

https://doi.org/10.1182/blood.V124.21.2408.2408

Published: 2014

Journal Articles

Monitoring ADAMTS13 Autoantibody Titer Using a Novel Quantitative Radioimmunoprecipitation Assay In Patients With Acquired Thrombotic Thrombocytopenic Purpura

Atsuko Igari, Takanori Moriki, MD, PhD, Hideo Wada, MD, Kenji Soejima, PhD, Mitsuru Murata, MD, PhD

Blood (2013) 122 (21): 3561.

https://doi.org/10.1182/blood.V122.21.3561.3561

Published: 2013

Journal Articles

Bruton′s Tyrosine Kinase Inhibitor Ibrutinib Interferes With Constitutive and Induced Pre-B Cell Receptor Signaling In B-Cell Acute Lymphoblastic Leukemia

Ekaterina Kim, MS, Stefan Koehrer, MD, Nathalie Y. Rosin, PhD, Zhiqiang Wang, Ph.D., Deborah A. Thomas, MD, Farhad Ravandi, MD, Steven M. Kornblau, MD, Hagop M. Kantarjian, MD, Susan O'Brien, MD, Zeev Estrov, MD, Joseph J. Buggy, PhD, Markus Muschen, MD, PhD, Richard E. Davis, MD, Jan A. Burger, MD, PhD

Blood (2013) 122 (21): 1399.

https://doi.org/10.1182/blood.V122.21.1399.1399

Published: 2013

Journal Articles

Resveratrol Regulates Fetal Hemoglobin Production by Inhibiting KLF1 and BCL11A in KU812 Cells

Davies G Agyekum, Zhong Chen, MD, Haiyan Xiao, Megan Yu, Niren Patel, MBBS, Betty S Pace, MD, Steffen E. Meiler, MD

Blood (2012) 120 (21): 1000.

https://doi.org/10.1182/blood.V120.21.1000.1000

Published: 2012

Journal Articles

A Novel Missense Mutation Asp69Gly in the Platelet Glycoprotein Ib(beta) Gene in Two Families with Bernard-Soulier Syndrome,

Wolf A Hassenpflug, MD, Belinda Weber, Tobias Obser, Ulrich Budde, MD, Reinhard Schneppenheim, MD, PhD

Blood (2011) 118 (21): 3300.

https://doi.org/10.1182/blood.V118.21.3300.3300

Published: 2011

Journal Articles

Quantitative Analysis of the Domain-Specific Autoantibodies to ADAMTS13 in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Atsuko Igari, Takanori Moriki, MD, PhD, Yusuke Yamaguchi, Terumichi Nakagawa, Hideo Wada, MD, Masanori Matsumoto, MD, PhD, Yoshihiro Fujimura, MD, PhD, Kenji Soejima, PhD, Mitsuru Murata, MD

Blood (2011) 118 (21): 1167.

https://doi.org/10.1182/blood.V118.21.1167.1167

Published: 2011

Journal Articles

Frequency of Bleeding Disorders in Women Presenting Menorrhagia in the North of Iran

Ghasem Janbabaei, MD, Samaneh Borhani, MD, Masoumeh Rashidi, Touraj Farazmandfar, MSc, Ramin Shekarriz, MD, Mohammad Khademloo, PhD, Ardeshir Ghavamzadeh

Blood (2011) 118 (21): 4660.

https://doi.org/10.1182/blood.V118.21.4660.4660

Published: 2011

Journal Articles

Nuclear Factor of Activated T-Cells (NFAT1): Potential Novel Target in T-Cell Acute Lymphocytic Leukemia (T-ALL)

Hongyan Lu, PhD, Shicheng Yang, MD PhD, Xiao Huang, BSc, Harun El Masri, PhD, Paul C Trampont, Amandeep Salhotra, MD, James G Farmar, PhD, Alexander J Wendling, BSc, Mary J Laughlin, MD

Blood (2011) 118 (21): 4634.

https://doi.org/10.1182/blood.V118.21.4634.4634

Published: 2011

Journal Articles

Functional Characterization of Three VWF- A1 Domain Mutations Causing Type 2 Von Willebrand Disease.

Maha Othman, MD, MSc, PhD, Rouzbeh Chegeni, BSc, MSc, PhD, Linda M Vickars, MD, Emmanuel J Favaloro, PhD, M.A.I.M.S, David Lillicrap

Blood (2009) 114 (22): 1305.

https://doi.org/10.1182/blood.V114.22.1305.1305

Published: 2009

Journal Articles

Soluble Monomeric Von Willebrand Factor A1A2A3 (R1450E) Mutant Fragment Enhances Shear-Induced Platelet Aggregation and Platelet Adhesion to Fibrin(ogen) Via αIIbβ3 Under High Shear Stress.

Miguel A. Cruz, PhD, Katie E. Sowa, Scott M. Smith

Blood (2009) 114 (22): 4025.

https://doi.org/10.1182/blood.V114.22.4025.4025

Published: 2009

Journal Articles

Results of a World Wide Survey On the Diagnostic Dilemma Between Type 2B Von Willeband Disease and the PT-VWD.

Maha Othman, MD, MSc, PhD, Alexander Hamilton, David Lillicrap, MD

Blood (2009) 114 (22): 4436.

https://doi.org/10.1182/blood.V114.22.4436.4436

Published: 2009

Journal Articles

Aberrant Expression and Activation of Nuclear Factor of Activated T cells (NFAT1) in Human T-Cell Acute Lymphocytic Leukemia (T-ALL) May Contribute to Leukemogenesis

Peter Haviernik, PhD, Mathew L Lesniewski, PhD, Richard Patrick Weitzel, BSc, Mary J Laughlin, MD

Blood (2008) 112 (11): 4474.

https://doi.org/10.1182/blood.V112.11.4474.4474

Published: 2008

Journal Articles

Incidence of HPA-9b in Testing for Neonatal Alloimmune Thrombocytopenia.

James W. Smith, BSc, Kristen Chamberlain, BSc, Diana Moffatt, MLT, Aurelio Santos, BSMT, Denise Neutel, MLT, Jane Moore, BSc, Theodore E. Warkentin, MD, Donald M. Arnold, MD, John G. Kelton, MD

Blood (2007) 110 (11): 3214.

https://doi.org/10.1182/blood.V110.11.3214.3214

Published: 2007

Journal Articles

No Immunogenicity Found to Antithrombin alfa in Human Clinical Studies.

Johan Frieling, Carol Ziomek, Nick Masiello, Lynn Peters, Susan Richards, Karen Welch, Valerie Theobald, Judith Bonfiglio, LiHow Chen, Harry Meade

Blood (2007) 110 (11): 3197.

https://doi.org/10.1182/blood.V110.11.3197.3197

Published: 2007

Journal Articles

Studies with the Nanobody That Detects the Gain-of-Function of von Willebrand Factor in a Cohort of Patients with Type 2B von Willebrand Disease: Correlation with Platelet Count, VWF Multimers and Molecular Defects.

Augusto B. Federici, MD, Luciano Baronciani, PhD, Maria T. Canciani, PhD, Barbara Moroni, PhD, Carlo Balduini, MD, Pier M. Mannucci, MD, Peter J. Lenting, PhD, Philip G. de Groot, PhD

Blood (2006) 108 (11): 1011.

https://doi.org/10.1182/blood.V108.11.1011.1011

Published: 2006

NARROW

Inhibitory Effect of a Novel DNA Aptamer with Artificial Nucleic Bases for Von Willebrand Factor A1 Domain on Platelet Thrombosis Formation

International, Practice-Based Recommendations for Prediction of Bleedings and Anti-Platelet/Anti-Coagulant (AP/AC) Co-Medications in CLL Patients Taking Ibrutinib

Low Intensity Vibration Treatment Reduces Myeloma Cell-Induced Osteoclast Formation By Inhibiting IL-6 and GFI-1 Production By MM Cells

Differentially Expressed Protein Patterns in Chronic Lymphocytic Leukemia (CLL) after Thymosin beta4 (Tb4) and Lenalidomide (Len) Treatment: Two-Dimensional Gel Electrophoresis (2DE) Analysis

Laboratory Assessment of Anti-Coagulant Properties of a Von Willebrand Factor Targeted Aptamer

Loss of PTEN in Pediatric T-Cell Acute Lymphoblastic Leukemia Patients: Proteomic and Molecular Characterization

Monitoring ADAMTS13 Autoantibody Titer Using a Novel Quantitative Radioimmunoprecipitation Assay In Patients With Acquired Thrombotic Thrombocytopenic Purpura

Bruton′s Tyrosine Kinase Inhibitor Ibrutinib Interferes With Constitutive and Induced Pre-B Cell Receptor Signaling In B-Cell Acute Lymphoblastic Leukemia

Resveratrol Regulates Fetal Hemoglobin Production by Inhibiting KLF1 and BCL11A in KU812 Cells

A Novel Missense Mutation Asp69Gly in the Platelet Glycoprotein Ib(beta) Gene in Two Families with Bernard-Soulier Syndrome,

Quantitative Analysis of the Domain-Specific Autoantibodies to ADAMTS13 in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Frequency of Bleeding Disorders in Women Presenting Menorrhagia in the North of Iran

Nuclear Factor of Activated T-Cells (NFAT1): Potential Novel Target in T-Cell Acute Lymphocytic Leukemia (T-ALL)

Functional Characterization of Three VWF- A1 Domain Mutations Causing Type 2 Von Willebrand Disease.

Soluble Monomeric Von Willebrand Factor A1A2A3 (R1450E) Mutant Fragment Enhances Shear-Induced Platelet Aggregation and Platelet Adhesion to Fibrin(ogen) Via αIIbβ3 Under High Shear Stress.

Results of a World Wide Survey On the Diagnostic Dilemma Between Type 2B Von Willeband Disease and the PT-VWD.

Aberrant Expression and Activation of Nuclear Factor of Activated T cells (NFAT1) in Human T-Cell Acute Lymphocytic Leukemia (T-ALL) May Contribute to Leukemogenesis

Incidence of HPA-9b in Testing for Neonatal Alloimmune Thrombocytopenia.

No Immunogenicity Found to Antithrombin alfa in Human Clinical Studies.

Studies with the Nanobody That Detects the Gain-of-Function of von Willebrand Factor in a Cohort of Patients with Type 2B von Willebrand Disease: Correlation with Platelet Count, VWF Multimers and Molecular Defects.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only